Dr. Talukder is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1919 Old Spanish Trail
Houston, TX 77030
Education & Training
University of WashingtonFellowship, Hematology and Medical Oncology, 2020 - 2023
Baylor College of MedicineResidency, Internal Medicine, 2016 - 2019
The University of Texas Health Science Center at San AntonioClass of 2016
Certifications & Licensure
TX State Medical License 2018 - 2026
WA State Medical License 2020 - 2024- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- 13 citationsTreatment Rechallenge With Immune Checkpoint Inhibitors in Advanced Urothelial Carcinoma.Dimitrios Makrakis, Dimitra Rafailia Bakaloudi, Rafee Talukder, Genevieve Ihsiu Lin, Leonidas N Diamantopoulos
Clinical Genitourinary Cancer. 2023-04-01 - 8 citationsResponse and Outcomes of Maintenance Avelumab After Platinum-Based Chemotherapy (PBC) in Patients With Advanced Urothelial Carcinoma (aUC): "Real World" Experience.Dimitra Rafailia Bakaloudi, Rafee Talukder, Genevieve Ihsiu Lin, Dimitrios Makrakis, Leonidas N Diamantopoulos
Clinical Genitourinary Cancer. 2023-10-01 - 35 citationsEfficacy of enfortumab vedotin in advanced urothelial cancer: Analysis from the Urothelial Cancer Network to Investigate Therapeutic Experiences (UNITE) study.Vadim S Koshkin, Nicholas Henderson, Marihella James, Divya Natesan, Dory Freeman
Cancer. 2022-03-15
Abstracts/Posters
- Differential Induction Among Younger Patients Diagnosed with Secondary Acute Myelogenous Leukemia Is Feasible By Cytogenetic/Molecular Risk StratificationRafee Talukder, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
Lectures
- Superior Outcome in Elderly AML Patients Receiving Adjuvant Serotonin-Reuptake-Inhibitors during Induction61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
- Predictive Factors for Complete Remission and Survival in AML Patients Failing to Achieve Adequate Bone Marrow Day 14 Blast Eradication2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
